Copy number variant discrepancy resolution using the ClinGen dosage sensitivity map results in updated clinical interpretations in ClinVar

Erin R. Riggs, Tristan Nelson, Andrew Merz, Todd Ackley, Brian Bunke, Christin D. Collins, Morag N. Collinson, Yao Shan Fan, McKinsey L. Goodenberger, Denae M. Golden, Linda Haglund-Hazy, Danijela Krgovic, Allen N. Lamb, Zoe Lewis, Guang Li, Yajuan Liu, Jeanne Meck, Whitney Neufeld-Kaiser, Cassandra K. Runke, Jennifer N. Sanmann & 8 others Dimitri J. Stavropoulos, Emma Strong, Meng Su, Marwan K. Tayeh, Nadja Kokalj Vokac, Erik C Thorland, Erica Andersen, Christa L. Martin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Conflict resolution in genomic variant interpretation is a critical step toward improving patient care. Evaluating interpretation discrepancies in copy number variants (CNVs) typically involves assessing overlapping genomic content with focus on genes/regions that may be subject to dosage sensitivity (haploinsufficiency (HI) and/or triplosensitivity (TS)). CNVs containing dosage sensitive genes/regions are generally interpreted as “likely pathogenic” (LP) or “pathogenic” (P), and CNVs involving the same known dosage sensitive gene(s) should receive the same clinical interpretation. We compared the Clinical Genome Resource (ClinGen) Dosage Map, a publicly available resource documenting known HI and TS genes/regions, against germline, clinical CNV interpretations within the ClinVar database. We identified 251 CNVs overlapping known dosage sensitive genes/regions but not classified as LP or P; these were sent back to their original submitting laboratories for re-evaluation. Of 246 CNVs re-evaluated, an updated clinical classification was warranted in 157 cases (63.8%); no change was made to the current classification in 79 cases (32.1%); and 10 cases (4.1%) resulted in other types of updates to ClinVar records. This effort will add curated interpretation data into the public domain and allow laboratories to focus attention on more complex discrepancies.

Original languageEnglish (US)
Pages (from-to)1650-1659
Number of pages10
JournalHuman Mutation
Volume39
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Haploinsufficiency
Gene Dosage
Genome
Public Sector
Negotiating
Genes
Patient Care
Databases

Keywords

  • ClinGen
  • ClinVar
  • CNV discrepancy
  • dosage sensitivity
  • variant interpretation

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Riggs, E. R., Nelson, T., Merz, A., Ackley, T., Bunke, B., Collins, C. D., ... Martin, C. L. (2018). Copy number variant discrepancy resolution using the ClinGen dosage sensitivity map results in updated clinical interpretations in ClinVar. Human Mutation, 39(11), 1650-1659. https://doi.org/10.1002/humu.23610

Copy number variant discrepancy resolution using the ClinGen dosage sensitivity map results in updated clinical interpretations in ClinVar. / Riggs, Erin R.; Nelson, Tristan; Merz, Andrew; Ackley, Todd; Bunke, Brian; Collins, Christin D.; Collinson, Morag N.; Fan, Yao Shan; Goodenberger, McKinsey L.; Golden, Denae M.; Haglund-Hazy, Linda; Krgovic, Danijela; Lamb, Allen N.; Lewis, Zoe; Li, Guang; Liu, Yajuan; Meck, Jeanne; Neufeld-Kaiser, Whitney; Runke, Cassandra K.; Sanmann, Jennifer N.; Stavropoulos, Dimitri J.; Strong, Emma; Su, Meng; Tayeh, Marwan K.; Kokalj Vokac, Nadja; Thorland, Erik C; Andersen, Erica; Martin, Christa L.

In: Human Mutation, Vol. 39, No. 11, 01.11.2018, p. 1650-1659.

Research output: Contribution to journalArticle

Riggs, ER, Nelson, T, Merz, A, Ackley, T, Bunke, B, Collins, CD, Collinson, MN, Fan, YS, Goodenberger, ML, Golden, DM, Haglund-Hazy, L, Krgovic, D, Lamb, AN, Lewis, Z, Li, G, Liu, Y, Meck, J, Neufeld-Kaiser, W, Runke, CK, Sanmann, JN, Stavropoulos, DJ, Strong, E, Su, M, Tayeh, MK, Kokalj Vokac, N, Thorland, EC, Andersen, E & Martin, CL 2018, 'Copy number variant discrepancy resolution using the ClinGen dosage sensitivity map results in updated clinical interpretations in ClinVar', Human Mutation, vol. 39, no. 11, pp. 1650-1659. https://doi.org/10.1002/humu.23610
Riggs, Erin R. ; Nelson, Tristan ; Merz, Andrew ; Ackley, Todd ; Bunke, Brian ; Collins, Christin D. ; Collinson, Morag N. ; Fan, Yao Shan ; Goodenberger, McKinsey L. ; Golden, Denae M. ; Haglund-Hazy, Linda ; Krgovic, Danijela ; Lamb, Allen N. ; Lewis, Zoe ; Li, Guang ; Liu, Yajuan ; Meck, Jeanne ; Neufeld-Kaiser, Whitney ; Runke, Cassandra K. ; Sanmann, Jennifer N. ; Stavropoulos, Dimitri J. ; Strong, Emma ; Su, Meng ; Tayeh, Marwan K. ; Kokalj Vokac, Nadja ; Thorland, Erik C ; Andersen, Erica ; Martin, Christa L. / Copy number variant discrepancy resolution using the ClinGen dosage sensitivity map results in updated clinical interpretations in ClinVar. In: Human Mutation. 2018 ; Vol. 39, No. 11. pp. 1650-1659.
@article{89bfd96e606e4df689dda0f3c8152201,
title = "Copy number variant discrepancy resolution using the ClinGen dosage sensitivity map results in updated clinical interpretations in ClinVar",
abstract = "Conflict resolution in genomic variant interpretation is a critical step toward improving patient care. Evaluating interpretation discrepancies in copy number variants (CNVs) typically involves assessing overlapping genomic content with focus on genes/regions that may be subject to dosage sensitivity (haploinsufficiency (HI) and/or triplosensitivity (TS)). CNVs containing dosage sensitive genes/regions are generally interpreted as “likely pathogenic” (LP) or “pathogenic” (P), and CNVs involving the same known dosage sensitive gene(s) should receive the same clinical interpretation. We compared the Clinical Genome Resource (ClinGen) Dosage Map, a publicly available resource documenting known HI and TS genes/regions, against germline, clinical CNV interpretations within the ClinVar database. We identified 251 CNVs overlapping known dosage sensitive genes/regions but not classified as LP or P; these were sent back to their original submitting laboratories for re-evaluation. Of 246 CNVs re-evaluated, an updated clinical classification was warranted in 157 cases (63.8{\%}); no change was made to the current classification in 79 cases (32.1{\%}); and 10 cases (4.1{\%}) resulted in other types of updates to ClinVar records. This effort will add curated interpretation data into the public domain and allow laboratories to focus attention on more complex discrepancies.",
keywords = "ClinGen, ClinVar, CNV discrepancy, dosage sensitivity, variant interpretation",
author = "Riggs, {Erin R.} and Tristan Nelson and Andrew Merz and Todd Ackley and Brian Bunke and Collins, {Christin D.} and Collinson, {Morag N.} and Fan, {Yao Shan} and Goodenberger, {McKinsey L.} and Golden, {Denae M.} and Linda Haglund-Hazy and Danijela Krgovic and Lamb, {Allen N.} and Zoe Lewis and Guang Li and Yajuan Liu and Jeanne Meck and Whitney Neufeld-Kaiser and Runke, {Cassandra K.} and Sanmann, {Jennifer N.} and Stavropoulos, {Dimitri J.} and Emma Strong and Meng Su and Tayeh, {Marwan K.} and {Kokalj Vokac}, Nadja and Thorland, {Erik C} and Erica Andersen and Martin, {Christa L.}",
year = "2018",
month = "11",
day = "1",
doi = "10.1002/humu.23610",
language = "English (US)",
volume = "39",
pages = "1650--1659",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Copy number variant discrepancy resolution using the ClinGen dosage sensitivity map results in updated clinical interpretations in ClinVar

AU - Riggs, Erin R.

AU - Nelson, Tristan

AU - Merz, Andrew

AU - Ackley, Todd

AU - Bunke, Brian

AU - Collins, Christin D.

AU - Collinson, Morag N.

AU - Fan, Yao Shan

AU - Goodenberger, McKinsey L.

AU - Golden, Denae M.

AU - Haglund-Hazy, Linda

AU - Krgovic, Danijela

AU - Lamb, Allen N.

AU - Lewis, Zoe

AU - Li, Guang

AU - Liu, Yajuan

AU - Meck, Jeanne

AU - Neufeld-Kaiser, Whitney

AU - Runke, Cassandra K.

AU - Sanmann, Jennifer N.

AU - Stavropoulos, Dimitri J.

AU - Strong, Emma

AU - Su, Meng

AU - Tayeh, Marwan K.

AU - Kokalj Vokac, Nadja

AU - Thorland, Erik C

AU - Andersen, Erica

AU - Martin, Christa L.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Conflict resolution in genomic variant interpretation is a critical step toward improving patient care. Evaluating interpretation discrepancies in copy number variants (CNVs) typically involves assessing overlapping genomic content with focus on genes/regions that may be subject to dosage sensitivity (haploinsufficiency (HI) and/or triplosensitivity (TS)). CNVs containing dosage sensitive genes/regions are generally interpreted as “likely pathogenic” (LP) or “pathogenic” (P), and CNVs involving the same known dosage sensitive gene(s) should receive the same clinical interpretation. We compared the Clinical Genome Resource (ClinGen) Dosage Map, a publicly available resource documenting known HI and TS genes/regions, against germline, clinical CNV interpretations within the ClinVar database. We identified 251 CNVs overlapping known dosage sensitive genes/regions but not classified as LP or P; these were sent back to their original submitting laboratories for re-evaluation. Of 246 CNVs re-evaluated, an updated clinical classification was warranted in 157 cases (63.8%); no change was made to the current classification in 79 cases (32.1%); and 10 cases (4.1%) resulted in other types of updates to ClinVar records. This effort will add curated interpretation data into the public domain and allow laboratories to focus attention on more complex discrepancies.

AB - Conflict resolution in genomic variant interpretation is a critical step toward improving patient care. Evaluating interpretation discrepancies in copy number variants (CNVs) typically involves assessing overlapping genomic content with focus on genes/regions that may be subject to dosage sensitivity (haploinsufficiency (HI) and/or triplosensitivity (TS)). CNVs containing dosage sensitive genes/regions are generally interpreted as “likely pathogenic” (LP) or “pathogenic” (P), and CNVs involving the same known dosage sensitive gene(s) should receive the same clinical interpretation. We compared the Clinical Genome Resource (ClinGen) Dosage Map, a publicly available resource documenting known HI and TS genes/regions, against germline, clinical CNV interpretations within the ClinVar database. We identified 251 CNVs overlapping known dosage sensitive genes/regions but not classified as LP or P; these were sent back to their original submitting laboratories for re-evaluation. Of 246 CNVs re-evaluated, an updated clinical classification was warranted in 157 cases (63.8%); no change was made to the current classification in 79 cases (32.1%); and 10 cases (4.1%) resulted in other types of updates to ClinVar records. This effort will add curated interpretation data into the public domain and allow laboratories to focus attention on more complex discrepancies.

KW - ClinGen

KW - ClinVar

KW - CNV discrepancy

KW - dosage sensitivity

KW - variant interpretation

UR - http://www.scopus.com/inward/record.url?scp=85054611143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054611143&partnerID=8YFLogxK

U2 - 10.1002/humu.23610

DO - 10.1002/humu.23610

M3 - Article

VL - 39

SP - 1650

EP - 1659

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 11

ER -